Trials to watch: Four ALS drugs to keep an eye on
There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.
There are a total of 12 candidates in mid to late-stage trials for ALS poised to enter the market in the next five years.